SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar control, often alongside diet and exercise. This combination medication targets insulin resistance and glucose absorption, making it a common choice for those needing dual-action therapy.

Common effects of Segluromet 7.5 mg/1 may include urinary tract infections, genital yeast infections, and gastrointestinal discomfort. Some users report increased urination or low blood sugar, especially when combined with other diabetes medications.

Handle Segluromet 7.5 mg/1 with care, especially if you have kidney issues, as it may affect kidney function. Avoid alcohol, as it can increase the risk of low blood sugar. Always consult a healthcare provider before starting this medication.

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol and some blood pressure medications can also affect its performance. Always inform your healthcare provider about all medications you are taking.